19-Oct-2016 - Almac Group’s Diagnostics business will engage with pharma to validate the link between its immune response assay and checkpoint inhibitor based therapy.
19-Oct-2016 - This week CordenPharma announced the completion of its new highly potent API process bay for category 4 compounds.
17-Oct-2016 - Catalent has entered into an agreement with Moderna Therapeutics to support the company’s proprietary production process.
13-Oct-2016 - CMC Biologics and IDT Biologika have added Cerbios-Pharma SA and Oncotec Pharma Produktion GmbH to the companies’ PROVEO Partnership – a strategic collaboration for manufacturing antibody drug conjugates (ADCs).
13-Oct-2016 - With the top 500 molecules in development having a commercial potential of $180bn by 2022, being first-to-market is critical says Pfizer.
06-Oct-2016 - Lonza and Boehringer-Ingelheim dominate the consolidated biologics CMO space but disposable technologies and improved yields are beginning to change this, says PharmSource’s Jim Miller.
05-Oct-2016 - MabPlex International is expanding its biomanufacturing facilities in China to meet biologic demand for “the foreseeable future.”
05-Oct-2016 - Alcami has announced its first to market Protect Your Brand™ offering, which it said will support companies looking to implement a backup supply option.
03-Oct-2016 - Empower Pharmacy has opened a new 15,000-square-foot facility as it looks to establish long-term viability in the compounding pharmacy industry.
27-Sep-2016 - Pharmaron has acquired MSD’s Hoddesdon, UK-based Good Manufacturing Practice (GMP) standard facilities to advance its API and formulation development.
27-Sep-2016 - The latest in a series of investments, Alcami has strengthened its analytical services capabilities at its Edison, New Jersey-based site.
22-Sep-2016 - Colorcon and Dow have expanded a nine year controlled release alliance to include further solubility, coating and ion exchange platforms.
22-Sep-2016 - In its first year of operations, IDT Biologika’s contract manufacturing facility in Rockville, Maryland has experienced rapid growth, which it expects to continue as construction carries on.
21-Sep-2016 - Yesterday, Almac Group announced a $5.2m investment in its US-based operations, which its global VP of operations said will support customers “across the drug development lifecycle.”
20-Sep-2016 - In conjunction with its 20th year of business in North America, Almac Group has announced a $5.2m investment at its Durham, North Carolina facilities.
20-Sep-2016 - The full-service contract development and manufacturing organization (CDMO) for investigational medicinal products has purchased a new building to expand its high containment manufacturing and development operations.
16-Sep-2016 - Since 2011, Samsung Biologics has built two plants, gained Bristol-Myers Squibb and Roche as clients and launched an IPO. With a third facility under construction, Biopharma-Reporter visited to see the...
14-Sep-2016 - Lonza has licensed rights to synthetic adeno-associated viral (AAV) vectors developed by scientists at US hearing research centre, Massachusetts Eye and Ear.
13-Sep-2016 - Catalent has announced its intention to buy Pharmatek Laboratories to boost its drug bioavailability offering.
13-Sep-2016 - Japanese glass solution provider AGC Asahi Glass has bought Germany’s Biomeva in a bid to launch itself into the international microbial CMO space.
13-Sep-2016 - Avid Bioservices will construct a clinical manufacturing plant later this year just months after production began at a second facility.
12-Sep-2016 - LI-COR Biosciences has expanded its production facility to offer contract manufacturing for early-phase cGMP materials.
12-Sep-2016 - Spanish API maker Suanfarma has acquired a stake in contract manufacturer and spray-drying specialist Idifarma, boosting its international presence.
07-Sep-2016 - The latest in a series of investments, Cambrex has recently expanded its Sweden-based site as part of its ongoing investment in small molecule API manufacturing across its global network of...
07-Sep-2016 - AMRI has said integrating recent Italian acquisition Prime European Therapeuticals, also known as Euticals, will involve layoffs.